TickerFacts.

Earth Science Tech, Inc. (ETST): Capital Expenditures

Annual figures by period end, from SEC filings.

$756.6K
Year ended 2026-03-31
$565.8K
Trailing 12 months to 2026-06-30
2015-03-31: $69.0K2024-03-31: $26.5K2025-03-31: $753.2K2026-03-31: $756.6K$756.6K
2015-03-31 Capital Expenditures (USD) 2026-03-31
Period endedCapital ExpendituresChange YoYSource filing
2026-03-31$756.6K+0.5%2026-06-18, From 2025-04-01
2025-03-31$753.2Kn/m2026-06-18, From 2024-04-01
2024-03-31$26.5Kn/a2024-06-28, From 2023-04-01
No annual figure between 2015-03-31 and 2024-03-31.
2015-03-31$69.0Kn/a2016-05-10, From 2014-04-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Earth Science Tech, Inc. (ETST)2026-03-31$756.6K+0.5%
Verrica Pharmaceuticals Inc. (VRCA)2025-12-31$0-100.0%
Sunshine Biopharma Inc. (SBFM)2025-12-31$174.5K-89.5%
Lftd Partners Inc. (LIFD)2025-12-31$121.6K-61.2%
Bioharvest Sciences Inc. (BHST)2025-12-31$2.35M-16.9%
BGM Group Ltd. (BGM)2025-09-30$1.57M+552.4%
Zomedica Corp. (ZOMDF)2025-12-31$567.0K-89.1%
Verastem, Inc. (VSTM)2024-12-31$28.0Kn/a
Foghorn Therapeutics Inc. (FHTX)2025-12-31$50.0K-94.5%

Compare ETST, VRCA, SBFM, LIFD side by side · Screen every company in Pharmaceutical Preparations ↗